Fehm et al. also used the Adna breast cancer select assay (Adnagen, Langenhagen, Germany), a reverse transcriptase (RT) PCR test for detecting mRNA transcripts of three tumor-associated markers (HER2, MUC1, and GA733-2). Here, ERBB2 is linked to breast carcinoma.